ponatinib
takeda,otsuka,incyte
['ponatinib', 'ph+ all']
our dr. elias jabbour presented at #asco23 today about a study he led showing treatment with ponatinib plus reduced intensity chemotherapy has the potential to be standard of care in patients with newly diagnosed ph+ all. learn about it: #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789